Skip to main content

Advertisement

Log in

Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature

  • Review
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Metabolic syndrome, that is, obesity, hypertension, hyperlipidemia, and insulin resistance with hyperinsulinemia, is a new disease entity prevailing worldwide, and nonalcoholic steatohepatitis (NASH) is believed to be a hepatic expression of this syndrome. NASH is characterized by zone 3-dominant hepatic steatosis with ballooned hepatocytes and Mallory bodies, zone 3 pericellular and perivenular fibrosis with or without bridging fibrosis, and lobular inflammatory cell infiltration. Indeed, 90% of NASH has been revealed to be complicated by visceral obesity, and two-thirds of NASH patients fulfill the criteria of metabolic syndrome. Therefore, a variety of lifestyle-related diseases such as obesity, hypertension, hyperlipidemia, and diabetes mellitus may share the same background. NASH is most prevalent and well characterized in Caucasians; however, little is known about its occurrence in Asia-Oceania, because obesity has not been frequent in countries in these areas. Obesity is expected to become a serious social problem in Asia-Oceania in the next two decades, so we need to prevent a corresponding increase of NASH. For that purpose, we need to know much about not only NASH but also ourselves. To elucidate the status of NASH in Japan, recent progress in the study of NASH in Japan is reviewed in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. WE Jaques (1953) ArticleTitleThe incidence of portal cirrhosis and fatty metamorphosis in patients dying with diabetes mellitus N Engl J Med 249 442–5 Occurrence Handle13087619 Occurrence Handle1:STN:280:DyaG2c%2FgvVelug%3D%3D Occurrence Handle10.1056/NEJM195309102491104

    Article  PubMed  CAS  Google Scholar 

  2. H Robbers P Strohfeldt C Kruger (1968) ArticleTitleDifferential diagnosis between diabetic and alcoholic fatty liver. A study of 171 diabetics and 100 chronic alcoholics Ger Med Mon 13 124–5 Occurrence Handle5656867 Occurrence Handle1:STN:280:DyaF1c3os1SgtA%3D%3D

    PubMed  CAS  Google Scholar 

  3. J Ludwig TR Viggiano DB McGill BJ Oh (1980) ArticleTitleNonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 434–8 Occurrence Handle7382552 Occurrence Handle1:STN:280:DyaL3c3gvVeqtQ%3D%3D

    PubMed  CAS  Google Scholar 

  4. K Omagari Y Kadokawa J Masuda I Egawa T Sawa H Hazama et al. (2002) ArticleTitleFatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics J Gastroenterol Hepatol 17 1098–105 Occurrence Handle12201871 Occurrence Handle10.1046/j.1440-1746.2002.02846.x

    Article  PubMed  Google Scholar 

  5. BA Neuschwander-Tetri SH Caldwell (2003) ArticleTitleNonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 1202–19 Occurrence Handle12717402 Occurrence Handle10.1053/jhep.2003.50193

    Article  PubMed  Google Scholar 

  6. EM Brunt (2001) ArticleTitleNonalcoholic steatohepatitis: definition and pathology Semin Liver Dis 21 3–16 Occurrence Handle11296695 Occurrence Handle1:STN:280:DC%2BD3MrgsVGrtg%3D%3D Occurrence Handle10.1055/s-2001-12925

    Article  PubMed  CAS  Google Scholar 

  7. EM Brunt CG Janney AM Di Bisceglie BA Neuschwander-Tetri BR Bacon (1999) ArticleTitleNonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467–74 Occurrence Handle10484010 Occurrence Handle1:STN:280:DyaK1MvhtFyisw%3D%3D Occurrence Handle10.1111/j.1572-0241.1999.01377.x

    Article  PubMed  CAS  Google Scholar 

  8. T Saibara (2005) ArticleTitleNonalcoholic steatohepatitis in Asia-Oceania Hepatol Res 33 54–7

    Google Scholar 

  9. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii, 1–253

  10. N Yoshiike H Lwin (2005) ArticleTitleEpidemiological aspects of obesity and NASH/NAFLD in Japan Hepatol Res 33 77–82 Occurrence Handle16226488 Occurrence Handle10.1016/j.hepres.2005.09.008

    Article  PubMed  Google Scholar 

  11. WHO expert consultation: appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63

    Google Scholar 

  12. N Iwamoto Y Ogawa S Kajihara A Hisatomi T Yasutake T Yoshimura et al. (2001) ArticleTitleGln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver Clin Chim Acta 314 85–91 Occurrence Handle11718682 Occurrence Handle1:CAS:528:DC%2BD3MXosFKksLg%3D Occurrence Handle10.1016/S0009-8981(01)00633-7

    Article  PubMed  CAS  Google Scholar 

  13. C Murata T Watanabe H Furuya Y Sugioka H Mikurube A Yokoyama et al. (2003) ArticleTitleAldehyde dehydrogenase 2 and beta3-adrenergic receptor gene polymorphisms: their association with elevated liver enzymes and metabolic syndrome Metabolism 52 1096–101 Occurrence Handle14506613 Occurrence Handle1:CAS:528:DC%2BD3sXntVGlu74%3D Occurrence Handle10.1016/S0026-0495(03)00183-5

    Article  PubMed  CAS  Google Scholar 

  14. C Namikawa S-P Zhang JR Vyselaar Y Nozaki Y Nemoto M Ono et al. (2004) ArticleTitlePolymorphisms in microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in Japanese patients with nonalcoholic steatohepatitis J Hepatol 40 781–6 Occurrence Handle15094225 Occurrence Handle1:CAS:528:DC%2BD2cXjtFOiurw%3D Occurrence Handle10.1016/j.jhep.2004.01.028

    Article  PubMed  CAS  Google Scholar 

  15. Y Nozaki T Saibara Y Nemoto M Ono N Akisawa S Iwasaki et al. (2005) ArticleTitlePolymorphisms of interleukin 1-beta and beta-3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis Alcohol Clin Exp Res 28 106S–10S Occurrence Handle10.1111/j.1530-0277.2004.tb03226.x

    Article  Google Scholar 

  16. J Song KA da Costa LM Fischer M Kohlmeier L Kwock S Wang et al. (2005) ArticleTitlePolymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD) FASEB J 19 1266–71 Occurrence Handle16051693 Occurrence Handle1:CAS:528:DC%2BD2MXnt1OisLs%3D Occurrence Handle10.1096/fj.04-3580com

    Article  PubMed  CAS  Google Scholar 

  17. H Takagi S Hagiwara H Hashizume D Kanda K Sato N Sohara et al. (2006) ArticleTitleAdult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis J Hepatol 44 236–9 Occurrence Handle16278034 Occurrence Handle1:CAS:528:DC%2BD2MXht12ktLvF Occurrence Handle10.1016/j.jhep.2005.08.024

    Article  PubMed  CAS  Google Scholar 

  18. T Ichikawa K Hamasaki H Ishikawa E Ejima K Eguchi K Nakao (2003) ArticleTitleNon-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency Gut 52 914 Occurrence Handle12740357 Occurrence Handle1:STN:280:DC%2BD3s3hvFSkuw%3D%3D Occurrence Handle10.1136/gut.52.6.914

    Article  PubMed  CAS  Google Scholar 

  19. K Nakajima E Hashimoto H Kaneda K Tokushige K Shiratori N Hizuka et al. (2005) ArticleTitlePediatric nonalcoholic steatohepatitis associated with hypopituitarism J Gastroenterol 40 312–5 Occurrence Handle15830293 Occurrence Handle10.1007/s00535-004-1541-4

    Article  PubMed  Google Scholar 

  20. Y Nemoto T Saibara Y Ogawa T Zhang N Xu M Ono et al. (2002) ArticleTitleTamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen Intern Med 41 345–50 Occurrence Handle12058881 Occurrence Handle1:CAS:528:DC%2BD38XlslOit78%3D

    PubMed  CAS  Google Scholar 

  21. T Matsumoto N Suzuki H Watanabe M Irie K Iwata A Anan et al. (2004) ArticleTitleNonalcoholic steatohepatitis associated with psoriasis vulgaris J Gastroenterol 39 1102–5 Occurrence Handle15580405 Occurrence Handle10.1007/s00535-004-1451-5

    Article  PubMed  Google Scholar 

  22. T Saibara (2005) ArticleTitlePreface Hepatol Res 33 63 Occurrence Handle16246620 Occurrence Handle10.1016/j.hepres.2005.09.004

    Article  PubMed  Google Scholar 

  23. A Suzuki K Lindor J St Saver J Lymp F Mendes A Muto et al. (2005) ArticleTitleEffect of changes on body weight and lifestyle in nonalcoholic fatty liver disease J Hepatol 43 1060–6 Occurrence Handle16140415 Occurrence Handle1:CAS:528:DC%2BD2MXht1egsrjJ Occurrence Handle10.1016/j.jhep.2005.06.008

    Article  PubMed  CAS  Google Scholar 

  24. SH Caldwell DH Oelsner JC Iezzoni EE Hespenheide EH Battle CJ Driscoll (1999) ArticleTitleCryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 664–9 Occurrence Handle10051466 Occurrence Handle1:STN:280:DyaK1M7mt1emtw%3D%3D Occurrence Handle10.1002/hep.510290347

    Article  PubMed  CAS  Google Scholar 

  25. M Shimada E Hashimoto M Taniai K Hasegawa H Okuda N Hayashi et al. (2002) ArticleTitleHepatocellular carcinoma in patients with non-alcoholic steatohepatitis J Hepatol 37 154–60 Occurrence Handle12076877 Occurrence Handle10.1016/S0168-8278(02)00099-5

    Article  PubMed  Google Scholar 

  26. E Hashimoto S Yatsuji H Kaneda Y Yoshioka M Taniai K Tokushige et al. (2005) ArticleTitleThe characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease Hepatol Res 33 72–6 Occurrence Handle16203174 Occurrence Handle10.1016/j.hepres.2005.09.007

    Article  PubMed  Google Scholar 

  27. K Kiyosawa T Umemura T Ichijo A Matsumoto K Yoshizawa A Gad et al. (2004) ArticleTitleHepatocellular carcinoma: recent trends in Japan Gastroenterology 127 IssueID5 Suppl 1 S17–26 Occurrence Handle15508082 Occurrence Handle10.1053/j.gastro.2004.09.012

    Article  PubMed  Google Scholar 

  28. M Nakamuta S Morizono Y Soejima T Yoshizumi S Aishima S Takasugi et al. (2005) ArticleTitleShort-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation Transplantation 80 608–12 Occurrence Handle16177634 Occurrence Handle1:CAS:528:DC%2BD2MXhtVajs7nF Occurrence Handle10.1097/01.tp.0000166009.77444.f3

    Article  PubMed  CAS  Google Scholar 

  29. CA Matteoni ZM Younossi T Gramlich N Boparai YC Liu AJ McCullough (1999) ArticleTitleNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1413–9 Occurrence Handle10348825 Occurrence Handle1:STN:280:DyaK1M3nvVamtw%3D%3D Occurrence Handle10.1016/S0016-5085(99)70506-8

    Article  PubMed  CAS  Google Scholar 

  30. S Chitturi S Abeygunasekera GC Farrell J Holmes-Walker JM Hui C Fung et al. (2002) ArticleTitleNASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 373–9 Occurrence Handle11826411 Occurrence Handle1:CAS:528:DC%2BD38XhsVGrt74%3D Occurrence Handle10.1053/jhep.2002.30692

    Article  PubMed  CAS  Google Scholar 

  31. American Gastroenterological Association American Gastroenterological (2002) ArticleTitleAssociation medical position statement: nonalcoholic fatty liver disease Gastroenterology 123 1702–4 Occurrence Handle10.1053/gast.2002.36569

    Article  Google Scholar 

  32. G Marchesini E Bugianesi G Forlani F Cerrelli M Lenzi R Manini et al. (2003) ArticleTitleNonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 917–23 Occurrence Handle12668987 Occurrence Handle10.1053/jhep.2003.50161

    Article  PubMed  Google Scholar 

  33. T Saibara (2003) ArticleTitleCan an increase of body mass index by 1 kg/m2 be a risk for obesity-related diseases? J Gastroenterol 38 1022–3 Occurrence Handle14614617 Occurrence Handle10.1007/s00535-003-1209-5

    Article  PubMed  Google Scholar 

  34. M Okamoto Y Takeda Y Yoda K Kobayashi MA Fujino Z Yamagata (2003) ArticleTitleThe association of fatty liver and diabetes risk J Epidemiol 13 15–21 Occurrence Handle12587609

    PubMed  Google Scholar 

  35. T Kadowaki Y Miyake R Hagura Y Akanuma H Kajinuma N Kuzuya et al. (1984) ArticleTitleRisk factors for worsening to diabetes in subjects with impaired glucose tolerance Diabetologia 26 44–9 Occurrence Handle6368299 Occurrence Handle1:STN:280:DyaL2c7lvFartA%3D%3D Occurrence Handle10.1007/BF00252262

    Article  PubMed  CAS  Google Scholar 

  36. T Iwasaki A Nakajima M Yoneda Y Yamada K Mukasa K Fujita et al. (2005) ArticleTitleSerum ferritin is associated with visceral fat area and subcutaneous fat area Diabetes Care 28 2486–91 Occurrence Handle16186284 Occurrence Handle1:CAS:528:DC%2BD2MXhtFGqtrrN

    PubMed  CAS  Google Scholar 

  37. H Cortez-Pinto MC de Moura CP Day (2006) ArticleTitleNon-alcoholic steatohepatitis: from cell biology to clinical practice J Hepatol 44 197–208 Occurrence Handle16274837 Occurrence Handle1:CAS:528:DC%2BD2MXht12ktLvJ Occurrence Handle10.1016/j.jhep.2005.09.002

    Article  PubMed  CAS  Google Scholar 

  38. S Kojima N Watanabe M Numata T Ogawa S Matsuzaki (2003) ArticleTitleIncrease in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background J Gastroenterol 38 954–61 Occurrence Handle14614602 Occurrence Handle10.1007/s00535-003-1178-8

    Article  PubMed  Google Scholar 

  39. K Nomura E Yano T Shinozaki K Tagawa (2004) ArticleTitleEfficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups J Occup Health 46 423–8 Occurrence Handle15613764 Occurrence Handle1:CAS:528:DC%2BD2MXltVCiuw%3D%3D Occurrence Handle10.1539/joh.46.423

    Article  PubMed  CAS  Google Scholar 

  40. M Ishii Y Yoshioka W Ishida Y Kaneko F Fujiwara H Taneichi et al. (2005) ArticleTitleLiver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects Tohoku J Exp Med 206 23–30 Occurrence Handle15802872 Occurrence Handle1:CAS:528:DC%2BD2MXktVOgsLo%3D Occurrence Handle10.1620/tjem.206.23

    Article  PubMed  CAS  Google Scholar 

  41. AJ Sanyal (2002) ArticleTitleAGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 1705–25 Occurrence Handle12404245 Occurrence Handle10.1053/gast.2002.36572

    Article  PubMed  Google Scholar 

  42. M Hamaguchi T Kojima N Takeda T Nakagawa H Taniguchi K Fujii et al. (2005) ArticleTitleThe metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 722–8 Occurrence Handle16287793 Occurrence Handle1:CAS:528:DC%2BD2MXht1yntLrN

    PubMed  CAS  Google Scholar 

  43. H Ishii (2006) ArticleTitleHepatocellular carcinoma and non-alcoholic fatty liver disease: major liver diseases emerging from the Asia-Pacific Region J Gastroenterol Hepatol 21 IssueID1 Pt 1 6–7 Occurrence Handle16706801 Occurrence Handle10.1111/j.1440-1746.2005.04238.x

    Article  PubMed  Google Scholar 

  44. M Nakamuta M Kohjima S Morizono K Kotoh T Yoshimoto I Miyagi et al. (2005) ArticleTitleEvaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Int J Mol Med 16 631–5 Occurrence Handle16142397 Occurrence Handle1:CAS:528:DC%2BD2MXhtFeqsbbJ

    PubMed  CAS  Google Scholar 

  45. A Suzuki P Angulo J Lymp J St Sauver A Muto T Okada et al. (2005) ArticleTitleChronological development of elevated aminotransferases in a nonalcoholic population Hepatology 41 64–71 Occurrence Handle15690483 Occurrence Handle1:CAS:528:DC%2BD2MXotFWqsA%3D%3D Occurrence Handle10.1002/hep.20543

    Article  PubMed  CAS  Google Scholar 

  46. K Fujikawa K Ohata T Honda S Miyazoe T Ichikawa H Ishikawa et al. (2004) ArticleTitleNonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction Intern Med 43 289–94 Occurrence Handle15168770 Occurrence Handle10.2169/internalmedicine.43.289

    Article  PubMed  Google Scholar 

  47. J Bjorkegren A Beigneux MO Bergo JJ Maher SG Young (2002) ArticleTitleBlocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury J Biol Chem 277 5476–83 Occurrence Handle11739387 Occurrence Handle1:CAS:528:DC%2BD38XhsFCjtrY%3D Occurrence Handle10.1074/jbc.M108514200

    Article  PubMed  CAS  Google Scholar 

  48. H Yokoyama H Hirose H Ohgo I Saito (2004) ArticleTitleInverse association between serum adiponectin level and transaminase activities in Japanese male workers J Hepatol 41 19–24 Occurrence Handle15246202 Occurrence Handle1:CAS:528:DC%2BD2cXls1Wns7Y%3D Occurrence Handle10.1016/j.jhep.2004.03.003

    Article  PubMed  CAS  Google Scholar 

  49. T Saibara Y Nozaki Y Nemoto M Ono S Onishi (2002) ArticleTitleLow socioeconomic status and coronary artery disease Lancet 359 IssueID9310 980 Occurrence Handle11918948 Occurrence Handle10.1016/S0140-6736(02)08005-4

    Article  PubMed  Google Scholar 

  50. K Chin T Nakamura K Takahashi K Sumi Y Ogawa H Masuzaki et al. (2003) ArticleTitleEffects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients Am J Med 114 370–6 Occurrence Handle12714126 Occurrence Handle1:CAS:528:DC%2BD3sXjtVKht7k%3D Occurrence Handle10.1016/S0002-9343(02)01570-X

    Article  PubMed  CAS  Google Scholar 

  51. IR Wanless JS Lentz (1990) ArticleTitleFatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1106–10 Occurrence Handle2227807 Occurrence Handle1:STN:280:DyaK3M%2FjtlGqsQ%3D%3D

    PubMed  CAS  Google Scholar 

  52. JD Browning JD Horton (2004) ArticleTitleMolecular mediators of hepatic steatosis and liver injury J Clin Invest 114 147–52 Occurrence Handle15254578 Occurrence Handle1:CAS:528:DC%2BD2cXlvFWms7c%3D Occurrence Handle10.1172/JCI200422422

    Article  PubMed  CAS  Google Scholar 

  53. Y Eguchi T Eguchi T Mizuta Y Ide T Yasutake R Iwakiri et al. (2006) ArticleTitleVisceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease J Gastroenterol 41 462–9 Occurrence Handle16799888 Occurrence Handle1:CAS:528:DC%2BD28XmtFGqu7Y%3D Occurrence Handle10.1007/s00535-006-1790-5

    Article  PubMed  CAS  Google Scholar 

  54. KL Donnelly CI Smith SJ Schwarzenberg J Jessurun MD Boldt EJ Parks (2005) ArticleTitleSources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 1343–51 Occurrence Handle15864352 Occurrence Handle1:CAS:528:DC%2BD2MXktFSktLk%3D Occurrence Handle10.1172/JCI200523621

    Article  PubMed  CAS  Google Scholar 

  55. Y Nemoto K Toda M Ono K Fujikawa-Adachi T Saibara S Onishi et al. (2000) ArticleTitleAltered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice J Clin Invest 105 1819–25 Occurrence Handle10862797 Occurrence Handle1:CAS:528:DC%2BD3cXkt1WqsLY%3D Occurrence Handle10.1172/JCI9575

    Article  PubMed  CAS  Google Scholar 

  56. M Fukumoto K Masuda Y Ogawa A Nishioka T Ohnishi Y Murata et al. (2005) ArticleTitleIn vivo imaging of hepatic fatty acid metabolism in patients with nonalcoholic steatohepatitis using semiquantitative 123-I-BMIPP liver scan Hepatol Res 33 105–9 Occurrence Handle16890172 Occurrence Handle1:CAS:528:DC%2BD2MXht1GnurvF Occurrence Handle10.1016/j.hepres.2005.09.015

    Article  PubMed  CAS  Google Scholar 

  57. T Yoshikawa K Toda Y Nemoto M Ono S Iwasaki T Maeda et al. (2002) ArticleTitleAromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration Hepatol Res 22 278–87 Occurrence Handle11929713 Occurrence Handle1:CAS:528:DC%2BD38XksFSqt7s%3D Occurrence Handle10.1016/S1386-6346(01)00145-0

    Article  PubMed  CAS  Google Scholar 

  58. T Saibara S Onishi Y Ogawa S Yoshida H Enzan (1999) ArticleTitleBezafibrate for tamoxifen-induced non-alcoholic steatohepatitis Lancet 353 1802 Occurrence Handle10348023 Occurrence Handle1:STN:280:DyaK1M3nsFOkuw%3D%3D Occurrence Handle10.1016/S0140-6736(05)75907-9

    Article  PubMed  CAS  Google Scholar 

  59. IR Wanless K Shiota (2004) ArticleTitleThe pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis Semin Liver Dis 24 99–106 Occurrence Handle15085490 Occurrence Handle10.1055/s-2004-823104

    Article  PubMed  Google Scholar 

  60. ZM Yao DE Vance (1989) ArticleTitleHead group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes J Biol Chem 264 11373–80 Occurrence Handle2738069 Occurrence Handle1:CAS:528:DyaL1MXksFClurg%3D

    PubMed  CAS  Google Scholar 

  61. PS Vermeulen S Lingrell Z Yao DE Vance (1997) ArticleTitlePhosphatidylcholine biosynthesis is required for secretion of truncated apolipoprotein Bs from McArdle RH7777 cells only when a neutral lipid core is formed J Lipid Res 38 447–58 Occurrence Handle9101426 Occurrence Handle1:CAS:528:DyaK2sXis12qsL4%3D

    PubMed  CAS  Google Scholar 

  62. DR Hoffman EO Uthus WE Cornatzer (1980) ArticleTitleEffect of diet on choline phosphotransferase, phosphatidylethanolamine methyltransferase and phosphatidyldimethylethanolamine methyltransferase in liver microsomes Lipids 15 439–46 Occurrence Handle6250002 Occurrence Handle1:CAS:528:DyaL3cXks12hsbY%3D

    PubMed  CAS  Google Scholar 

  63. Z Cui DE Vance (1996) ArticleTitleExpression of phosphatidylethanolamine N-methyltransferase-2 is markedly enhanced in long term choline-deficient rats J Biol Chem 271 2839–43 Occurrence Handle8576263 Occurrence Handle1:CAS:528:DyaK28XptVOitg%3D%3D Occurrence Handle10.1074/jbc.271.3.1732

    Article  PubMed  CAS  Google Scholar 

  64. ZM Yao DE Redu (1990) ArticleTitleVancection In VLD L, but not HDL, in plasma of rats deficient in choline Biochem Cell Biol 68 552–8 Occurrence Handle2344402 Occurrence Handle1:CAS:528:DyaK3cXhvFKisLo%3D Occurrence Handle10.1139/o90-079

    Article  PubMed  CAS  Google Scholar 

  65. SH Zeisel KA daCosta PD Franklin EA Alexander JT Lamont NF Sheard et al. (1991) ArticleTitleCholine, an essential nutrient for humans FASEB J 5 2093–8 Occurrence Handle2010061 Occurrence Handle1:CAS:528:DyaK3MXitVGrt7c%3D

    PubMed  CAS  Google Scholar 

  66. CJ Walkey LR Donohue R Bronson LB Agellon DE Vance (1997) ArticleTitleDisruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase Proc Natl Acad Sci U S A 94 12880–5 Occurrence Handle9371769 Occurrence Handle1:CAS:528:DyaK2sXnvFanu7g%3D Occurrence Handle10.1073/pnas.94.24.12880

    Article  PubMed  CAS  Google Scholar 

  67. KA Waite NR Cabilio DE Vance (2002) ArticleTitleCholine deficiency-induced liver damage is reversible in Pemt(−/−) mice J Nutr 132 68–71 Occurrence Handle11773510 Occurrence Handle1:CAS:528:DC%2BD38Xjt1enug%3D%3D

    PubMed  CAS  Google Scholar 

  68. AA Noga Y Zhao DE Vance (2002) ArticleTitleAn unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins J Biol Chem 277 42358–65 Occurrence Handle12193594 Occurrence Handle1:CAS:528:DC%2BD38XotF2gu78%3D Occurrence Handle10.1074/jbc.M204542200

    Article  PubMed  CAS  Google Scholar 

  69. X Zhu J Song MH Mar LJ Edwards Zeisel SH. Phosphatidylethanolamine (2003) ArticleTitleN-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline Biochem J 370 987–93 Occurrence Handle12466019 Occurrence Handle1:CAS:528:DC%2BD3sXhvFKhsL4%3D Occurrence Handle10.1042/BJ20021523

    Article  PubMed  CAS  Google Scholar 

  70. SV Drouva E LaPlante P Leblanc JJ Bechet H Clauser C Kordon (1986) ArticleTitleEstradiol activates methylating enzyme(s) involved in the conversion of phosphatidylethanolamine to phosphatidylcholine in rat pituitary membranes Endocrinol 119 2611–22 Occurrence Handle1:CAS:528:DyaL2sXktlegtbc%3D Occurrence Handle10.1210/endo-119-6-2611

    Article  CAS  Google Scholar 

  71. Y Ogawa Y Murata A Nishioka T Inomata S Yoshida (1998) ArticleTitleTamoxifen-induced fatty liver in patients with breast cancer Lancet 351 725 Occurrence Handle9504521 Occurrence Handle1:STN:280:DyaK1c7mtlSnuw%3D%3D Occurrence Handle10.1016/S0140-6736(05)78493-2

    Article  PubMed  CAS  Google Scholar 

  72. M Yoshimatsu Y Terasaki N Sakashita E Kiyota H Sato LJ van der Laan et al. (2004) ArticleTitleInduction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process Int J Exp Pathol 85 335–43 Occurrence Handle15566430 Occurrence Handle10.1111/j.0959-9673.2004.00401.x

    Article  PubMed  Google Scholar 

  73. D Cai M Yuan DF Frantz PA Melendez L Hansen J Lee SE Shoelson (2005) ArticleTitleLocal and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 183–90 Occurrence Handle15685173 Occurrence Handle1:CAS:528:DC%2BD2MXpvF2ntQ%3D%3D Occurrence Handle10.1038/nm1166

    Article  PubMed  CAS  Google Scholar 

  74. K Tomita G Tamiya S Ando K Ohsumi T Chiyo A Mizutani et al. (2006) ArticleTitleTumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice Gut 55 415–24 Occurrence Handle16174657 Occurrence Handle1:CAS:528:DC%2BD28Xis1Sjtrk%3D Occurrence Handle10.1136/gut.2005.071118

    Article  PubMed  CAS  Google Scholar 

  75. S Abiru K Migita Y Maeda M Daikoku M Ito K Ohata et al. (2006) ArticleTitleSerum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis Liver Int 26 39–45 Occurrence Handle16420507 Occurrence Handle1:CAS:528:DC%2BD28XisFCmu78%3D Occurrence Handle10.1111/j.1478-3231.2005.01191.x

    Article  PubMed  CAS  Google Scholar 

  76. K Tokushige E Hashimoto N Tsuchiya H Kaneda M Taniai K Shiratori (2005) ArticleTitleClinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis Alcohol Clin Exp Res 29 IssueID12 Suppl 298S–303S Occurrence Handle16385240 Occurrence Handle1:CAS:528:DC%2BD28Xms1eh

    PubMed  CAS  Google Scholar 

  77. H Nagai K Matsumaru G Feng N Kaplowitz (2002) ArticleTitleReduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes Hepatology 36 55–64 Occurrence Handle12085349 Occurrence Handle1:CAS:528:DC%2BD38XlslyrurY%3D Occurrence Handle10.1053/jhep.2002.33995

    Article  PubMed  CAS  Google Scholar 

  78. Y Sumida T Nakashima T Yoh M Furutani A Hirohama Y Kakisaka et al. (2003) ArticleTitleSerum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease J Hepatol 38 32–8 Occurrence Handle12480557 Occurrence Handle1:CAS:528:DC%2BD38XptlSqt7k%3D Occurrence Handle10.1016/S0168-8278(02)00331-8

    Article  PubMed  CAS  Google Scholar 

  79. Y Ikura M Ohsawa T Suekane H Fukushima H Itabe H Jomura et al. (2006) ArticleTitleLocalization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression Hepatology 43 506–14 Occurrence Handle16496325 Occurrence Handle1:CAS:528:DC%2BD28XjtVKqsbk%3D Occurrence Handle10.1002/hep.21070

    Article  PubMed  CAS  Google Scholar 

  80. Y Sumida T Nakashima T Yoh M Furutani A Hirohama Y Kakisaka et al. (2003) ArticleTitleSerum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease J Hepatol 38 32–8 Occurrence Handle12480557 Occurrence Handle1:CAS:528:DC%2BD38XptlSqt7k%3D Occurrence Handle10.1016/S0168-8278(02)00331-8

    Article  PubMed  CAS  Google Scholar 

  81. S Seki T Kitada T Yamada H Sakaguchi K Nakatani K Wakasa (2002) ArticleTitleIn situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J Hepatol 37 56–62 Occurrence Handle12076862 Occurrence Handle1:CAS:528:DC%2BD38XksFymu7s%3D Occurrence Handle10.1016/S0168-8278(02)00073-9

    Article  PubMed  CAS  Google Scholar 

  82. E Albano E Mottaran M Vidali E Reale S Saksena G Occhino et al. (2005) ArticleTitleImmune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis Gut 54 987–93 Occurrence Handle15951547 Occurrence Handle1:CAS:528:DC%2BD2MXmsFKqtr0%3D Occurrence Handle10.1136/gut.2004.057968

    Article  PubMed  CAS  Google Scholar 

  83. AE Feldstein A Canbay P Angulo M Taniai LJ Burgart KD Lindor et al. (2003) ArticleTitleHepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 437–43 Occurrence Handle12891546 Occurrence Handle10.1016/S0016-5085(03)00907-7

    Article  PubMed  Google Scholar 

  84. T Nakajima M Moriguchi T Katagishi S Sekoguchi T Nishikawa H Takashima et al. (2006) ArticleTitlePremature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD Liver Int 26 23–31 Occurrence Handle16420506 Occurrence Handle1:CAS:528:DC%2BD28XisFCmu74%3D Occurrence Handle10.1111/j.1478-3231.2005.01178.x

    Article  PubMed  CAS  Google Scholar 

  85. A Canbay AE Feldstein H Higuchi N Werneburg A Grambihler SF Bronk et al. (2003) ArticleTitleKupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression Hepatology 38 1188–98 Occurrence Handle14578857 Occurrence Handle1:CAS:528:DC%2BD3sXpsVOntrs%3D Occurrence Handle10.1053/jhep.2003.50472

    Article  PubMed  CAS  Google Scholar 

  86. VA Fadok DL Bratton PM Henson (2001) ArticleTitlePhagocyte receptors for apoptotic cells: recognition, uptake, and consequences J Clin Invest 108 957–62 Occurrence Handle11581295 Occurrence Handle1:CAS:528:DC%2BD3MXnt1KitLw%3D Occurrence Handle10.1172/JCI200114122

    Article  PubMed  CAS  Google Scholar 

  87. K Ueki T Kondo YH Tseng CR Kahn (2004) ArticleTitleCentral role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse Proc Natl Acad Sci U S A 101 10422–7 Occurrence Handle15240880 Occurrence Handle1:CAS:528:DC%2BD2cXmtVyrs7c%3D Occurrence Handle10.1073/pnas.0402511101

    Article  PubMed  CAS  Google Scholar 

  88. P Angulo LM Alba LM Petrovic LA Adams KD Lindor MD Jensen (2004) ArticleTitleLeptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease J Hepatol 41 943–9 Occurrence Handle15582127 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCgsLzF Occurrence Handle10.1016/j.jhep.2004.08.020

    Article  PubMed  CAS  Google Scholar 

  89. K Nakao K Nakata N Ohtsubo M Maeda T Moriuchi T Ichikawa et al. (2002) ArticleTitleAssociation between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults Am J Gastroenterol 97 1796–801 Occurrence Handle12135038 Occurrence Handle1:CAS:528:DC%2BD38Xmt1SitL0%3D Occurrence Handle10.1111/j.1572-0241.2002.05846.x

    Article  PubMed  CAS  Google Scholar 

  90. T Saibara (2003) ArticleTitle‘Insufficient’ leptin production for the fat mass: a risk factor for nonalcoholic steatohepatitis in obese patients? J Gastroenterol 38 522–3 Occurrence Handle12768401 Occurrence Handle10.1007/s00535-003-1113-z

    Article  PubMed  Google Scholar 

  91. K Ikejima K Okumura T Lang H Honda W Abe S Yamashina et al. (2005) ArticleTitleThe role of leptin in progression of non-alcoholic fatty liver disease Hepatol Res 33 151–4 Occurrence Handle16198623 Occurrence Handle1:CAS:528:DC%2BD2MXht1GnurjJ Occurrence Handle10.1016/j.hepres.2005.09.024

    Article  PubMed  CAS  Google Scholar 

  92. R Bataller RF Schwabe YH Choi L Yang YH Paik J Lindquist et al. (2003) ArticleTitleNADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis J Clin Invest 112 1383–94 Occurrence Handle14597764 Occurrence Handle1:CAS:528:DC%2BD3sXovVGqs7s%3D Occurrence Handle10.1172/JCI200318212

    Article  PubMed  CAS  Google Scholar 

  93. S Yokohama M Yoneda M Haneda S Okamoto M Okada K Aso et al. (2004) ArticleTitleTherapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology 40 1222–5 Occurrence Handle15382153 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCgt7jK Occurrence Handle10.1002/hep.20420

    Article  PubMed  CAS  Google Scholar 

  94. JA Oben T Roskams S Yang H Lin N Sinelli Z Li et al. (2003) ArticleTitleNorepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice Biochem Biophys Res Commun 308 284–92 Occurrence Handle12901866 Occurrence Handle1:CAS:528:DC%2BD3sXlvFGhurg%3D Occurrence Handle10.1016/S0006-291X(03)01360-3

    Article  PubMed  CAS  Google Scholar 

  95. H Sakugawa H Nakasone T Nakayoshi Y Kawakami T Yamashiro T Maeshiro et al. (2003) ArticleTitleClinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan Hepatogastroenterology 50 2005–8 Occurrence Handle14696453

    PubMed  Google Scholar 

  96. K Koike (2005) ArticleTitleSteatosis in chronic hepatitis C: fuel for overproduction of oxidative stress? J Gastroenterol 40 664–5 Occurrence Handle16007406 Occurrence Handle10.1007/s00535-005-1626-8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ono, M., Saibara, T. Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature. J Gastroenterol 41, 725–732 (2006). https://doi.org/10.1007/s00535-006-1876-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-006-1876-0

Key words

Navigation